Differences in cell lineage involvement between MDS-AML and de novo AML studied by fluorescence in situ hybridization in combination with morphology

European Journal of Haematology

Volumn 58, Issue 4, 1997, Pages 241-245

  Bernell, Per ^a   Arvidsson, Ingrid ^a   Hast, Robert ^a   Jacobsson, Björn ^a   Stenke, Leif ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

acute lymphoid leukaemia; acute myeloid leukaemia; clonality; cytogenetics; fluorescence in situ hybridization; morphology; myelodysplastic syndromes

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL LINEAGE; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; ERYTHROID CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTE; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0030943958     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb01661.x     Document Type: Article

References (22)

1. KOEFFLER HP. Myelodysplastic syndromes (preleukemia). Clin Haematol 1986: 15: 829-850.
2. GALTON DAG. The myelodysplastic syndromes. Scand J Haematol 1986: 36 (suppl 45): 11-20.
3. BRITO-BABAPULLE FMC, CATOVSKY D, GALTON DAG. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol 1987: 66: 445-450.
4. HAMBLIN T. The treatment of acute myeloid leukemia preceded by the myelodysplastic syndrome. Leuk Res 1992: 16: 101-108.
5. YUNIS JJ, IOBELL M, ARNESEN MA, et al. Refined chromosome study helps define prognostic subgroups in moust patient with primary myelodysplastic syndromes and acute myelogenous leukaemia. Br J Haematol 1988: 68:189-194.
6. PRCHAL JT, TROCKMORTON DW, CARROLL AJ, FUSON EW, GAMS RA, PRCHAL JF. A common progenitor for human myeloid and lymphoid cells. Nature 1978: 274: 590-591.
7. JANSSEN JWG, BUSCHLE M, LAYTON M, et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989: 73: 248.
8. RASKIND WH, TIRUMALI N, JACOBSON R, SINGER J, FIALKOW PJ. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984: 63: 1318-1325.
9. BRITO-BABAPULLE FMC, CATOVSKY D, GALTON DAG. Myelodysplastic relapse of de nova acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation. Br J Haematol 1988: 68: 411-415.
10. VAN LOM K, HAGEMEIJER A, VANDEKERCKOVE F, SMIT EME, LÖWENBERG B. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 1996, in press.
11. PINKEL D, SIRAUME T, GRAY JW. Cytogenetic analysis using quantative, high-sensitivity, fluorescence in situ hybridization. Proc Natl Acad Sci USA 1986: 83: 2934-2938.
12. ANASTASI J, VARDIMAN JW, RUDINSKY R, et al. Direct correlation of cytogenetic findings with cell morphology using in situ hybridization and analysis of suspicious cells in bone marrow specimens of 2 patients completing therapy for acute lymphoblastic leukemia. Blood 1991: 77: 2456-2462.
13. KIBBELAAR RE, VAN KAMP H, DREEF EJ, et al. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood 1992: 79: 1823-1828.
14. GERRITSEN WR, DONOHUE J, BAUMAN J, et al. Clonal analysis of myelodysplastic syndromes: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 1992: 80: 217-224.
15. VAN LOM K, HAGEMEIJER A, SMIT EME, LÖWENBERG B. In situ hybridization on May-Gru}dnwald-Giemsa stained bone marrow and blood smears of patients with hematologic disorders allow detection of cell-lineage-specific cytogenetic abnormalities. Blood 1993: 82: 884-888.
16. JACOBSSON B, BERNELL P, ARVIDSSON I, HAST R. Classical morphology, esterase cytochemistry and interphase cytogenetics off peripheral blood and bone marrow smears. J Histochem Cytochem, in press.
17. BERNELL P, JACOBSSON B, NORGREN A, HAST R. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia 1996: 10: 662-668.
18. MITELMAN F. (ed.) ISCN Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. Basel: Karger, 1991.
19. NYLUND SJ, RUUTU T, SAARINEN U, LARRAMENDY ML, KNUUTILA S. Detection of minimal residual disease during fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients. Leukemia 1994: 8: 587-594.
20. FIALKOW PJ, SINGER JW, RASKIND WH, et al. Clonal development, stem-cell differentiation, and clinical remission in acute nonlymphocytic leukemia. N Engl J Med 1987: 317: 468-473.
21. FEARON ER, BURKE PJ, SCHIFFER CA, ZEHNBAUER BA, VOGELSTEIN B. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N Engl J Med 1986: 315: 15-24.
22. NYLUND SJ, VERBEEK W, LARRAMENDY ML, et al. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8. Studied by simultaneous immunophenotyping and fluorescence in situ hybridization. Cancer Genet Cytogenet 1993: 70: 120-124